Literature DB >> 33534833

Anti-inflammatory activity of soluble chito-oligosaccharides (CHOS) on VitD3-induced human THP-1 monocytes.

Paiboon Jitprasertwong1, Munthipha Khamphio2, Phornsiri Petsrichuang2, Vincent G H Eijsink3, Wanangkan Poolsri4, Chatchai Muanprasat4, Kuntalee Rangnoi2, Montarop Yamabhai2.   

Abstract

Chito-oligosaccharides (CHOS) are oligomers of D-glucosamine and N-acetyl-glucosamine. Anti-inflammatory activities of a wide variety of CHOS mixtures have previously been reported, mainly based on studies with mouse models and murine macrophages. Since the mouse and human immune systems are quite different, gaining insight into the activity of CHOS on human cell lines, using well-characterized CHOS mixtures, is of considerable interest. Bacillus subtilis chitosanase (BsCsn46A) can efficiently convert chitosan to mixtures of water soluble low molecular weight CHOS. Here, the anti-inflammatory activity of a properly characterized CHOS mixture was studied, using human THP-1 cells that were differentiated to mature monocytes using vitamin D3. Addition of CHOS reduced the production of multiple pro-inflammatory cytokines associated with bacterial lipopolyssacharide (LPS)-stimulated inflammation, in a dose-dependent manner and without affecting cell viability. Interestingly, only minimal effects of CHOS were observed in similar experiments with phorbol 12-myristate 13-acetate- (PMA-) differentiated, macrophage-like, THP-1 cells. Altogether, in addition to showing promising biological effects of well-characterized low molecular weight soluble CHOS in a human system, the present study also points at Vitamin D3-stimulated THP-1 cells as a favorable system for assessing the anti-inflammatory activity of bioactive compounds.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33534833      PMCID: PMC7857634          DOI: 10.1371/journal.pone.0246381

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  30 in total

Review 1.  The resolution of inflammation and cancer.

Authors:  Juan Rodriguez-Vita; Toby Lawrence
Journal:  Cytokine Growth Factor Rev       Date:  2009-12-22       Impact factor: 7.638

2.  Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway.

Authors:  R L Kitchens; R J Ulevitch; R S Munford
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

3.  Determination of the degree of N-acetylation and the distribution of N-acetyl groups in partially N-deacetylated chitins (chitosans) by high-field n.m.r. spectroscopy.

Authors:  K M Vårum; M W Anthonsen; H Grasdalen; O Smidsrød
Journal:  Carbohydr Res       Date:  1991-04-02       Impact factor: 2.104

4.  The Pattern of Acetylation Defines the Priming Activity of Chitosan Tetramers.

Authors:  Sven Basa; Malathi Nampally; Talita Honorato; Subha N Das; Appa R Podile; Nour E El Gueddari; Bruno M Moerschbacher
Journal:  J Am Chem Soc       Date:  2020-01-13       Impact factor: 15.419

5.  Leptin enhances the secretion of interleukin (IL)-18, but not IL-1β, from human monocytes via activation of caspase-1.

Authors:  Paiboon Jitprasertwong; Katrin M Jaedicke; Christopher J Nile; Philip M Preshaw; John J Taylor
Journal:  Cytokine       Date:  2013-11-23       Impact factor: 3.861

Review 6.  Chitin research revisited.

Authors:  Feisal Khoushab; Montarop Yamabhai
Journal:  Mar Drugs       Date:  2010-06-28       Impact factor: 5.118

7.  Anti-inflammatory activity of chitooligosaccharides in vivo.

Authors:  João C Fernandes; Humberto Spindola; Vanessa de Sousa; Alice Santos-Silva; Manuela E Pintado; Francisco Xavier Malcata; João E Carvalho
Journal:  Mar Drugs       Date:  2010-05-28       Impact factor: 5.118

Review 8.  Enzymatic Modifications of Chitin, Chitosan, and Chitooligosaccharides.

Authors:  Michal Benedykt Kaczmarek; Katarzyna Struszczyk-Swita; Xingkang Li; Miroslawa Szczęsna-Antczak; Maurycy Daroch
Journal:  Front Bioeng Biotechnol       Date:  2019-09-27

Review 9.  Chitooligosaccharide and its derivatives: preparation and biological applications.

Authors:  Gaurav Lodhi; Yon-Suk Kim; Jin-Woo Hwang; Se-Kwon Kim; You-Jin Jeon; Jae-Young Je; Chang-Bum Ahn; Sang-Ho Moon; Byong-Tae Jeon; Pyo-Jam Park
Journal:  Biomed Res Int       Date:  2014-03-03       Impact factor: 3.411

Review 10.  The trinity of COVID-19: immunity, inflammation and intervention.

Authors:  Matthew Zirui Tay; Chek Meng Poh; Laurent Rénia; Paul A MacAry; Lisa F P Ng
Journal:  Nat Rev Immunol       Date:  2020-04-28       Impact factor: 108.555

View more
  3 in total

Review 1.  Multiple Roles of Chitosan in Mucosal Drug Delivery: An Updated Review.

Authors:  Paola Mura; Francesca Maestrelli; Marzia Cirri; Natascia Mennini
Journal:  Mar Drugs       Date:  2022-05-20       Impact factor: 6.085

2.  The Effect of N-Acetylation on the Anti-Inflammatory Activity of Chitooligosaccharides and Its Potential for Relieving Endotoxemia.

Authors:  Wentong Hao; Kecheng Li; Xiangyun Ge; Haoyue Yang; Chaojie Xu; Song Liu; Huahua Yu; Pengcheng Li; Ronge Xing
Journal:  Int J Mol Sci       Date:  2022-07-26       Impact factor: 6.208

Review 3.  Potential Medical Applications of Chitooligosaccharides.

Authors:  Sukumaran Anil
Journal:  Polymers (Basel)       Date:  2022-08-29       Impact factor: 4.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.